Bain Capital

In the latest episode of PEI's Spotlight podcast, the co-managing partner at the $185bn private equity firm discusses what tools effective investors need during times of uncertainty.

Japan is benefitting as some investors shift focus away from Chinese private equity, partner Naofumi Nishi tells PEI.

Heightened fairness requirements could lead to a rise in acquisition premiums, increased transaction costs and procedural complexity.

Bain Capital XIV will write equity cheques as large as $900m and will seek to make as many as 20 investments.

IK Partners' Frances Houweling, Partners Group's Jean Ghabache, and Bain Capital's Paul Moskowitz share their insight on the market's developments.

International GPs and LPs increasingly view Japan as one of the hottest growth markets for private equity as it gets lifted by macro tailwinds.

Addressing the needs of underserved groups provides an opportunity to boost returns and achieve impact.

As economic and geopolitical concerns permeate, GPs are arming themselves against fundraising uncertainty.

Inflows during the period were disproportionately buoyed by the $49bn raised for MGX Fund I in June.

Private capital should not be viewed as a replacement for government funding, but rather as a catalyst that brings commercial discipline and scale, according to the director general of the Royal United Services Institute speaking at a UK Private Capital event.

Global capital is pouring into Japan, yet fundraising data reveals a more uneven picture as domestic constraints and cyclical dynamics reshape the market.

From Japan Post Bank’s former private equity head to a buyout shop delivering 4.4x, PEI presents a rundown of seven managers you should probably get to know.

Private equity is zeroing in on healthtech investments that focus on technology-driven patient support.